ArticleThe New England journal of medicine2018

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.

Ranjana Advani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.